Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Jinxin Fertility Group Ltd. ( (HK:1951) ) is now available.
Jinxin Fertility Group Ltd. held its Annual General Meeting on June 26, 2025, where all proposed resolutions were approved by poll. Key resolutions included the adoption of the company’s audited financial statements for 2024, re-election of several directors, and the re-appointment of Deloitte Touche Tohmatsu as the company’s auditor. These decisions reflect the company’s ongoing commitment to maintaining strong governance and financial transparency, which are crucial for its stakeholders and market positioning.
The most recent analyst rating on (HK:1951) stock is a Buy with a HK$3.33 price target. To see the full list of analyst forecasts on Jinxin Fertility Group Ltd. stock, see the HK:1951 Stock Forecast page.
More about Jinxin Fertility Group Ltd.
Jinxin Fertility Group Ltd. operates in the healthcare industry, focusing on fertility services. The company offers a range of services related to assisted reproduction, including in vitro fertilization and other fertility treatments, primarily targeting markets in China and other regions.
Average Trading Volume: 72,094,433
Technical Sentiment Signal: Sell
Current Market Cap: HK$8.01B
Find detailed analytics on 1951 stock on TipRanks’ Stock Analysis page.